Showing results (61-70 of 111) with videos related to

Sort By:
Pageof 12
Frontiers in Immunology|March 8, 2021
Utilizing Computational Machine Learning Tools to Understand Immunogenic Breadth in the Context of a CD8 T-Cell Mediated HIV ResponseEd McGowan, Rachel Rosenthal, Andrew Fiore-Gartland, et al.
Frontiers in Immunology|March 29, 2021
A Novel Sample Selection Approach to Aid the Identification of Factors That Correlate With the Control of HIV-1 InfectionJulia Makinde, Eunice W Nduati, Anna Freni-Sterrantino, et al.
Viruses|January 27, 2021
HIV-1 Gag-Pol Sequences from Ugandan Early Infections Reveal Sequence Variants Associated with Elevated Replication CapacityAnne Kapaata, Sheila N Balinda, Rui Xu, et al.
The Journal of Infectious Diseases|February 6, 2010
Viral inhibition assay: a CD8 T cell neutralization assay for use in clinical trials of HIV-1 vaccine candidatesAggeliki Spentzou, Philip Bergin, Dilbinder Gill, et al.
Virus Evolution|January 21, 2026
Single genome amplification and molecular cloning of HIV-1 populations in acute HIV-1 infection: implications for studies on HIV-1 diversity and evolutionary rateAnthony Y Y Hsieh, Amin S Hassan, Jamirah Nazziwa, et al.
Viruses|February 26, 2022
Characterization of Near Full-Length Transmitted/Founder HIV-1 Subtype D and A/D Recombinant Genomes in a Heterosexual Ugandan Population (2006-2011)Sheila N Balinda, Anne Kapaata, Rui Xu, et al.
Clinical and Vaccine Immunology : CVI|January 25, 2013
Safety and immunogenicity of DNA prime and modified vaccinia ankara virus-HIV subtype C vaccine boost in healthy adultsPeter Hayes, Jill Gilmour, Andrea von Lieven, et al.
The Journal of Experimental Medicine|August 24, 2016
Balance between transmitted HLA preadapted and nonassociated polymorphisms is a major determinant of HIV-1 disease progressionDaniela C Mónaco, Dario A Dilernia, Andrew Fiore-Gartland, et al.
Plos One|August 8, 2015
A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African AdultsJuliet Mpendo, Gaudensia Mutua, Julien Nyombayire, et al.
AIDS Research and Human Retroviruses|July 30, 2010
A phase 2 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 vaccine based on adeno-associated virusEftyhia Vardas, Pontiano Kaleebu, Linda-Gail Bekker, et al.
Pageof 12